136 related articles for article (PubMed ID: 12378966)
1. Matrices of water-soluble drug using natural polymer and direct compression method.
Rosario NL; Ghaly ES
Drug Dev Ind Pharm; 2002 Sep; 28(8):975-88. PubMed ID: 12378966
[TBL] [Abstract][Full Text] [Related]
2. Development and evaluation of nifedipine controlled release tablets prepared using mucoadhesive swellable polymer.
Felician WA; Ghaly ES
Pharm Dev Technol; 2011 Oct; 16(5):536-41. PubMed ID: 20954856
[TBL] [Abstract][Full Text] [Related]
3. Prolonged intragastric drug delivery mediated by Eudragit® E-carrageenan polyelectrolyte matrix tablets.
Bani-Jaber A; Al-Aani L; Alkhatib H; Al-Khalidi B
AAPS PharmSciTech; 2011 Mar; 12(1):354-61. PubMed ID: 21302009
[TBL] [Abstract][Full Text] [Related]
4. Suitability of κ-carrageenan pellets for the formulation of multiparticulate tablets with modified release.
Ghanam D; Kleinebudde P
Int J Pharm; 2011 May; 409(1-2):9-18. PubMed ID: 21335073
[TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of drug release from aged prolonged polyethylene oxide tablet matrices: effect of excipient and drug type.
Shojaee S; Kaialy W; Cumming KI; Nokhodchi A
Pharm Dev Technol; 2016 Mar; 21(2):189-95. PubMed ID: 25410967
[TBL] [Abstract][Full Text] [Related]
6. Kinetic release of theophylline from hydrophilic swellable matrices.
Vargas CI; Ghaly ES
Drug Dev Ind Pharm; 1999 Sep; 25(9):1045-50. PubMed ID: 10518245
[TBL] [Abstract][Full Text] [Related]
7. The influence of polymer content on early gel-layer formation in HPMC matrices: The use of CLSM visualisation to identify the percolation threshold.
Mason LM; Campiñez MD; Pygall SR; Burley JC; Gupta P; Storey DE; Caraballo I; Melia CD
Eur J Pharm Biopharm; 2015 Aug; 94():485-92. PubMed ID: 26143369
[TBL] [Abstract][Full Text] [Related]
8. Sustained release characteristics of tablets prepared with mixed matrix of sodium carrageenan and chitosan: effect of polymer weight ratio, dissolution medium, and drug type.
Bani-Jaber A; Al-Ghazawi M
Drug Dev Ind Pharm; 2005 Mar; 31(3):241-7. PubMed ID: 15830719
[TBL] [Abstract][Full Text] [Related]
9. The effect of formulation composition and dissolution parameters on the gel strength of controlled release hydrogel tablets.
Roshdy MN; Schnaare RL; Schwartz JB
Pharm Dev Technol; 2001 Nov; 6(4):583-93. PubMed ID: 11775959
[TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery.
Reza MS; Quadir MA; Haider SS
J Pharm Pharm Sci; 2003; 6(2):282-91. PubMed ID: 12935440
[TBL] [Abstract][Full Text] [Related]
11. In vitro evaluation of theophylline matrices using xyloglucan.
Badillo N; Ghaly ES
Pharm Dev Technol; 2008; 13(6):481-6. PubMed ID: 18720251
[TBL] [Abstract][Full Text] [Related]
12. Theophylline loaded gastroretentive floating tablets based on hydrophilic polymers: preparation and in vitro evaluation.
Khan F; Ibn Razzak SM; Khan ZR; Azad MA; Chowdhury JA; Reza S
Pak J Pharm Sci; 2009 Apr; 22(2):155-61. PubMed ID: 19339225
[TBL] [Abstract][Full Text] [Related]
13. Assessment of xanthan gum based sustained release matrix tablets containing highly water-soluble propranolol HCl.
Ali A; Iqbal M; Akhtar N; Khan HM; Ullah A; Uddin M; Khan MT
Acta Pol Pharm; 2013; 70(2):283-9. PubMed ID: 23614284
[TBL] [Abstract][Full Text] [Related]
14. Use of acryclic and metacrylic acid derivatives as sustained release matrices for theophylline hydrate tablets.
Ofoefule SI; Chukwu A
Boll Chim Farm; 1999 Nov; 138(10):526-30. PubMed ID: 10765469
[TBL] [Abstract][Full Text] [Related]
15. Mechanical properties of excipients do not affect polymer matrix formation.
Chatterjee L; Rades T; Tucker IG
Int J Pharm; 2010 Jan; 384(1-2):87-92. PubMed ID: 19819317
[TBL] [Abstract][Full Text] [Related]
16. Graft copolymers of ethyl methacrylate on waxy maize starch derivatives as novel excipients for matrix tablets: drug release and fronts movement kinetics.
Marinich JA; Ferrero C; Jiménez-Castellanos MR
Eur J Pharm Biopharm; 2012 Apr; 80(3):674-81. PubMed ID: 22210473
[TBL] [Abstract][Full Text] [Related]
17. Factorial analysis of the influence of dissolution medium on drug release from carrageenan-diltiazem complexes.
Bonferoni MC; Rossi S; Ferrari F; Stavik E; Pena-Romero A; Caramella C
AAPS PharmSciTech; 2000 Jun; 1(2):E15. PubMed ID: 14727848
[TBL] [Abstract][Full Text] [Related]
18. Drug release from Carbomer 934 matrices.
Russo LI; Ghaly ES
P R Health Sci J; 2000 Jun; 19(2):131-7. PubMed ID: 10909708
[TBL] [Abstract][Full Text] [Related]
19. Development of oral controlled-release tablet formulations based on diltiazem-carrageenan complex.
Bonferoni MC; Rossi S; Ferrari F; Caramella C
Pharm Dev Technol; 2004; 9(2):155-62. PubMed ID: 15202574
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of ethylcellulose as matrices for controlled release drug delivery.
Quadir MA; Chanda E; Haider SS; Reza MD; Datta BK
Pak J Pharm Sci; 2005 Apr; 18(2):29-34. PubMed ID: 16431395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
